HER2+ Gastric Cancer Market Growth Driven by Advancements in ADCs and Targeted Therapies

The Global HER2+ Gastric Cancer Market was valued at approximately USD 1.2 billion in 2024 and is projected to reach USD 2 billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025–2033. This growth is driven by the increasing adopti...